This fast-paced recorded CaseWise™ symposium from CME Outfitters will bring real-world clinical decision-making to life. Through dynamic patient cases, learners will compare their treatment choices to those of leading experts, peers in the room, providers in the community, patients themselves, and even AI-based insights. Learners will see how evidence translates into practice, what doesn’t, and why. Designed to challenge assumptions and sharpen strategy, this immersive format empowers clinicians to immediately apply the latest IL-23 inhibitor data, enhance communication and shared decision-making, and deliver truly patient-centered IBD care.
In this CME Outfitters recorded symposium, expert faculty will guide learners on the implementation of routine HIV testing and on adopting a status-neutral approach to effectively promote prevention strategies and PrEP initiation. Faculty will evaluate current and emerging PrEP options, introduce emerging LAI PrEP options, and discuss optimal patient selection criteria, transitioning strategies, and monitoring considerations. Faculty will model integration of effective patient engagement strategies to collaboratively initiate PrEP treatment and support adherence.
In this CME Outfitters recorded webcast, expert faculty will guide learners through the burden of cUTI on individual patients and the broader healthcare system, identify opportunities for improved care and outcomes for patients with cUTI through the utilization of up-to-date guidelines and new and emerging antibiotic therapies, and help ensure that patients with cUTI are treated in the appropriate healthcare setting and are transitioned seamlessly between inpatient and outpatient care.
In the third activity of this EfficientCME webcast series, faculty guide learners through a step-by-step case discussion that mirrors real-world practice. Faculty demonstrate how to apply the latest IHC scoring strategies to distinguish HER2-low and ultralow disease, and model best practices for reporting results in ways that directly support therapeutic decision-making.
In the first activity of this EfficientCME webcast series, two leading breast oncologists and a partnering pathologist examine the evolving understanding of HER2 biology and explain why new testing and interpretation methods for HER2-low and ultralow expression in mBC are emerging. Through expert discussion, they explore key evidence driving this shift and what it means for clinical practice moving forward.
Obesity affects more than 44% of post-9/11 U.S. Veterans—far surpassing rates in the general population—and is closely tied to chronic health issues such as cardiovascular disease, osteoarthritis, and diabetes. Despite the known risks, uptake of evidence-based treatment remains low. Fewer than 5% of Veterans in VA obesity programs receive anti-obesity medications (AOMs), and fewer still achieve meaningful weight loss. Unfortunately, weight stigma persists in clinical encounters, eroding trust and limiting effective engagement. Moreover, Veterans often face unique structural and psychosocial challenges that complicate obesity care, including mental health concerns. This education initiative aims to equip health care professionals with current evidence on pharmacologic options, strategies for comprehensive care planning, and guidance for bias-free, respectful communication. With obesity recognized as a chronic disease requiring sustained intervention, education is critical to update perceptions and treatment pathways that improve outcomes for Veterans struggling with weight and its related complications.
